CMS Offers More Flexible Timeline for Second Round of Medicare Drug Price Negotiations
-
Jan 23, 2025
In one of its final days in office, Joe Biden’s administration announced the next 15 drugs selected for Medicare drug price negotiations. By June 1, 2025, CMS will submit the maximum fair price of each newly selected drug to the drug manufacturer, and the companies will have 30 days to respond to the initial offer by accepting it or providing a counteroffer.
For this second round of price negotiations authorized by the Inflation Reduction Act, CMS tweaked the rules guiding negotiations, offering manufacturers earlier meetings to discuss pricing offers and adding more opportunities for patients, advocacy groups and caregivers to provide input.
It is still unclear whether President Donald Trump will seek to stop the program or change the drugs selected.
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.